Polynovo Limited (AU:PNV) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
PolyNovo Limited has reported a 54.5% increase in sales for FY24, driven by strong growth in the U.S. and expansion into new markets such as Japan and India. The company is advancing its NovoSorb technology, capturing new indications and launching products worldwide. With solid financial health and ambitious global expansion, PolyNovo is positioning itself as a leader in soft tissue reconstruction.
For further insights into AU:PNV stock, check out TipRanks’ Stock Analysis page.